Research peptide · LY3298176
Tirazeptid 60mg
Buy Tirzepatide: GIP/GLP-1 dual agonist, 10-60mg from €69.99. ≥99% HPLC purity, CoA per batch, volume discounts, worldwide shipping. Research use only.
Research peptide · LY3298176
Buy Tirzepatide: GIP/GLP-1 dual agonist, 10-60mg from €69.99. ≥99% HPLC purity, CoA per batch, volume discounts, worldwide shipping. Research use only.
Research peptide · LY3298176
Buy Tirzepatide: GIP/GLP-1 dual agonist, 10-60mg from €69.99. ≥99% HPLC purity, CoA per batch, volume discounts, worldwide shipping. Research use only.
hatte davor das selbe bei einem anderen shop geholt aber spüre hier mehr
hatte davor das selbe bei einem anderen shop geholt aber spüre hier mehr
/ vial
Order today → Delivery Mon, Sep 28 – Tue, Oct 06 to United States
Payment Methods
/ vial
Order today → Delivery Mon, Sep 28 – Tue, Oct 06 to United States
Payment Methods
Independently verified quality
3,000+
satisfied researchers
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
3,000+ satisfied researchers
Tirzepatide 10mg - 1 Vial vial + 2 ml BAC water → concentration:
Per unit (10 IU)
0.75 mg
Steady-state plasma level after ~ 4 weeks with weekly administration.
Scientific references
Research details
Tirazeptid is a synthetic dual agonist that simultaneously targets GIP and GLP-1 receptors. Available as a 60mg vial in lyophilized powder form with complete batch documentation. Each vial contains high-purity peptide verified by HPLC analysis. Store refrigerated at 2–8°C for optimal stability.
GLP-1R and GIPR dual agonism: glucose-dependent insulin secretion, appetite suppression via hypothalamic satiety circuits, improved insulin sensitivity in adipose tissue, brown adipose tissue activation via GIPR
Beginner protocol
2.5 mg per week
Advanced protocol
2,5–15 mg/week (research context)
Note: The dosages listed correspond to typical ranges from published research literature. They do not replace advice from a qualified researcher or physician.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Tirzepatide comes in 10mg, 15mg, 20mg, 30mg and 60mg. Every strength can be ordered as a single vial or as a 2-vial or 3-vial pack.
Independently verified quality
3,000+
satisfied researchers
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
99.43%
Avg. purity 2026
4.8 ★
ProvenExpert
3,000+ satisfied researchers
Tirzepatide 10mg - 1 Vial vial + 2 ml BAC water → concentration:
Per unit (10 IU)
0.75 mg
Steady-state plasma level after ~ 4 weeks with weekly administration.
Scientific references
Research details
Tirazeptid is a synthetic dual agonist that simultaneously targets GIP and GLP-1 receptors. Available as a 60mg vial in lyophilized powder form with complete batch documentation. Each vial contains high-purity peptide verified by HPLC analysis. Store refrigerated at 2–8°C for optimal stability.
GLP-1R and GIPR dual agonism: glucose-dependent insulin secretion, appetite suppression via hypothalamic satiety circuits, improved insulin sensitivity in adipose tissue, brown adipose tissue activation via GIPR
Beginner protocol
2.5 mg per week
Advanced protocol
2,5–15 mg/week (research context)
Note: The dosages listed correspond to typical ranges from published research literature. They do not replace advice from a qualified researcher or physician.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.43% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
Tirzepatide comes in 10mg, 15mg, 20mg, 30mg and 60mg. Every strength can be ordered as a single vial or as a 2-vial or 3-vial pack.
Tirzepatid Wirkung Dosierung: duale GIP/GLP-1-Pharmakologie, PK, SURMOUNT- und SURPASS-Daten. Wissenschaftliche Forschungsmonografie.
Tirzepatide dosage from 2.5 to 15 mg/week: administration, mechanism of action and clinical data. 60mg vial, >=99% purity.
Peptide zum Abnehmen im Forschungsvergleich: GLP-1, GIP und Amylin. Studiendaten zu Retatrutid und Cagrilintid im Leitfaden.
Tirzepatid Wirkung Dosierung: duale GIP/GLP-1-Pharmakologie, PK, SURMOUNT- und SURPASS-Daten. Wissenschaftliche Forschungsmonografie.
Tirzepatide dosage from 2.5 to 15 mg/week: administration, mechanism of action and clinical data. 60mg vial, >=99% purity.
Peptide zum Abnehmen im Forschungsvergleich: GLP-1, GIP und Amylin. Studiendaten zu Retatrutid und Cagrilintid im Leitfaden.
